InsiderTrades

Form 4 for ALKS Alkermes plc.

Accepted 2024-02-21 00:00:00 ET · period of report 2024-02-18 · accession 0001127602-24-006170 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-02-21 2024-02-18+ ALKS Hopkinson Craig C. EVP R, D, Chief Medical Off F - Tax $31.22 -8,523 98.6K -8% -$266.1K
DM 2024-02-21 2024-02-18+ ALKS Hopkinson Craig C. EVP R, D, Chief Medical Off M - OptEx — +19.2K 103.2K +23% —
DM 2024-02-21 2024-02-18+ ALKS Hopkinson Craig C. EVP R, D, Chief Medical Off M - OptEx — -19.2K 17.8K -52% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Ordinary Shares 2024-02-18 F D 3,951 $32.18 92,883 D — —
2 Common Ordinary Shares 2024-02-18 M A 8,897 — 96,834 D — — (F1) Each restricted stock unit represents a contingent right to receive one ordinary share.
3 Common Ordinary Shares 2024-02-20 F D 4,572 $30.39 98,608 D — —
4 Common Ordinary Shares 2024-02-20 M A 10,297 — 103,180 D — — (F1) Each restricted stock unit represents a contingent right to receive one ordinary share.
5 Derivative Restricted Stock Unit Award 2024-02-20 M D 10,297 — 0 D — · — to — 10,297 Ordinary Shares (F1) Each restricted stock unit represents a contingent right to receive one ordinary share. (F3) Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/20/2021.
6 Derivative Restricted Stock Unit Award 2024-02-18 M D 8,897 — 17,793 D — · — to — 8,897 Ordinary Shares (F1) Each restricted stock unit represents a contingent right to receive one ordinary share. (F2) Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/18/2023.